← Japan Elevator Service Holdings Co. overview

Japan Elevator Service Holdings Co. vs Veralto: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Japan Elevator Service Holdings Co., Ltd. (6544.JP)

Veralto Corporation (VLTO)

Q3 2026
▲3

Veralto beats guidance, expands water treatment with two acquisitions

  • Q2 beat and raised 2026 guidance Veralto reported Q2 adjusted earnings of $1.11 per share, beating estimates by 11%, with sales up 7.6% to $1.47 billion. Management raised full-year core sales growth to 4-4.5% and adjusted EPS to $4.35-$4.43, implying 12-14% growth. This directly lifts the stock because it shows the business is growing faster than expected and management is confident about the rest of the year.

    This is the core earnings event that drove analyst upgrades and fair value increases.

  • Water Quality margin expands to 26.5% Veralto's Water Quality segment, its largest business, lifted adjusted operating margin to 26.5% from 25.9%, with profit up 12.6% to $241 million. Sales rose 10.1% to $908 million, helped by 5.7% core growth and 2.9% pricing. Profit growing faster than sales means the company is becoming more efficient, which supports a higher stock price if sustained.

    Margin expansion is a key driver of earnings growth and was highlighted as a positive signal for future profitability.

  • Acquisitions expand water treatment portfolio Veralto acquired Alfaa UV, an India-based ultraviolet water treatment company, and agreed to buy Cleanwater1 for $465 million. These deals add new products and geographic reach to the Water Quality business. Acquisitions can boost future sales and earnings, which is why the stock often rises when they are announced, though they also use cash and carry integration risk.

    These deals show Veralto is actively growing its core water business through acquisitions, a key part of its strategy.

  • Analyst targets rise but ratings stay cautious After Q2 results, Barclays raised its price target to $117 and Stifel to $114, lifting Veralto's fair value estimate to about $112.76. However, several firms including RBC, UBS, Citi, and Baird kept neutral ratings, saying the stock already reflects recent good performance. This means analysts see limited upside from here, which can cap price gains even as the business performs well.

    This shows the counterweight: strong results are already priced in, limiting further upside.

August 2026
▲3

Veralto beats guidance, expands water treatment with two acquisitions

  • Q2 beat and raised 2026 guidance Veralto reported Q2 adjusted earnings of $1.11 per share, beating estimates by 11%, with sales up 7.6% to $1.47 billion. Management raised full-year core sales growth to 4-4.5% and adjusted EPS to $4.35-$4.43, implying 12-14% growth. This directly lifts the stock because it shows the business is growing faster than expected and management is confident about the rest of the year.

    This is the core earnings event that drove analyst upgrades and fair value increases.

  • Water Quality margin expands to 26.5% Veralto's Water Quality segment, its largest business, lifted adjusted operating margin to 26.5% from 25.9%, with profit up 12.6% to $241 million. Sales rose 10.1% to $908 million, helped by 5.7% core growth and 2.9% pricing. Profit growing faster than sales means the company is becoming more efficient, which supports a higher stock price if sustained.

    Margin expansion is a key driver of earnings growth and was highlighted as a positive signal for future profitability.

  • Acquisitions expand water treatment portfolio Veralto acquired Alfaa UV, an India-based ultraviolet water treatment company, and agreed to buy Cleanwater1 for $465 million. These deals add new products and geographic reach to the Water Quality business. Acquisitions can boost future sales and earnings, which is why the stock often rises when they are announced, though they also use cash and carry integration risk.

    These deals show Veralto is actively growing its core water business through acquisitions, a key part of its strategy.

  • Analyst targets rise but ratings stay cautious After Q2 results, Barclays raised its price target to $117 and Stifel to $114, lifting Veralto's fair value estimate to about $112.76. However, several firms including RBC, UBS, Citi, and Baird kept neutral ratings, saying the stock already reflects recent good performance. This means analysts see limited upside from here, which can cap price gains even as the business performs well.

    This shows the counterweight: strong results are already priced in, limiting further upside.

Latest
▲3

Veralto beats guidance, expands water treatment with two acquisitions

  • Q2 beat and raised 2026 guidance Veralto reported Q2 adjusted earnings of $1.11 per share, beating estimates by 11%, with sales up 7.6% to $1.47 billion. Management raised full-year core sales growth to 4-4.5% and adjusted EPS to $4.35-$4.43, implying 12-14% growth. This directly lifts the stock because it shows the business is growing faster than expected and management is confident about the rest of the year.

    This is the core earnings event that drove analyst upgrades and fair value increases.

  • Water Quality margin expands to 26.5% Veralto's Water Quality segment, its largest business, lifted adjusted operating margin to 26.5% from 25.9%, with profit up 12.6% to $241 million. Sales rose 10.1% to $908 million, helped by 5.7% core growth and 2.9% pricing. Profit growing faster than sales means the company is becoming more efficient, which supports a higher stock price if sustained.

    Margin expansion is a key driver of earnings growth and was highlighted as a positive signal for future profitability.

  • Acquisitions expand water treatment portfolio Veralto acquired Alfaa UV, an India-based ultraviolet water treatment company, and agreed to buy Cleanwater1 for $465 million. These deals add new products and geographic reach to the Water Quality business. Acquisitions can boost future sales and earnings, which is why the stock often rises when they are announced, though they also use cash and carry integration risk.

    These deals show Veralto is actively growing its core water business through acquisitions, a key part of its strategy.

  • Analyst targets rise but ratings stay cautious After Q2 results, Barclays raised its price target to $117 and Stifel to $114, lifting Veralto's fair value estimate to about $112.76. However, several firms including RBC, UBS, Citi, and Baird kept neutral ratings, saying the stock already reflects recent good performance. This means analysts see limited upside from here, which can cap price gains even as the business performs well.

    This shows the counterweight: strong results are already priced in, limiting further upside.